Advertisement

Topics

Artemis receives Orphan designation for Malaria treatment artemisone

10:07 EST 8 Nov 2017 | CentreWatch

Artemis Therapeutics, a pharmaceutical company developing new therapies for the treatment of life-threatening infectious diseases, announced that the FDA granted orphan drug designation for Artemisone, the Company’s lead product candidate, for the treatment of malaria. “We are delighted Artemisone has received orphan drug designation from the FDA for the treatment of malaria,” stated Brian M. Culley, […]

The post Artemis receives Orphan designation for Malaria treatment artemisone appeared first on CenterWatch News Online.

Original Article: Artemis receives Orphan designation for Malaria treatment artemisone

NEXT ARTICLE

More From BioPortfolio on "Artemis receives Orphan designation for Malaria treatment artemisone"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...